Coralite Muscle And Joint Pain Relief Patch
NDC Package 65923-148-02
Package Information
Coralite Muscle And Joint Pain Relief (camphor, menthol, and mehtyl salicylate) patches is directionsopen pouch and remove patchcarefully peel off protective backing and apply sticky side to affected areaadults and children 12 years of age and older:clean and dry affected areaapply to affected area no more than3 times dailydo not wear patch for more than 8 hourschildren under 12 years of age: consult a doctor. This formulation utilizes a patch delivery system. Marketed by United Exchange Corporation, this product is identified by NDC 65923-148 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 853260 - camphor 1.2 % / menthol 5.7 % / methyl salicylate 6.3 % Medicated Patch
- RxCUI: 853260 - camphor 0.012 MG/MG / menthol 0.057 MG/MG / methyl salicylate 0.063 MG/MG Medicated Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65923 - United Exchange Corporation
- 65923-148 - Coralite Muscle And Joint Pain Relief
- 65923-148-02 - 1 PATCH in 1 POUCH / 1 g in 1 PATCH
- 65923-148 - Coralite Muscle And Joint Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65923-148-02 identifies a specific commercial package of 1 patch in 1 pouch / 1 g in 1 patch of Coralite Muscle And Joint Pain Relief, a human over the counter drug labeled by United Exchange Corporation. This patch is formulated for topical use and contains camphor (synthetic); menthol; methyl salicylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by United Exchange Corporation on October 23, 2018. The current certification is valid through December 31, 2026.
How is this United Exchange Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65923014802. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.